An evidence-based analysis of the management of N0 neck in patients with cancer of the parotid gland
- 3 October 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 19 (10) , 899-908
Abstract
Introduction: Management of clinically negative neck (cN0) in patients with parotid gland cancer is controversial. Treatment options can include observation, elective neck dissection or elective radiotherapy. Areas covered: We addressed the treatment options for cN0 patients with parotid gland cancer. A literature review was undertaken to determine the optimal management of this group of patients. Expert opinion: Patients with parotid carcinoma and clinically negative neck have various options for their management. The analysis of tumor stage, histology and grade is essential to better define patients at risk for occult lymph node metastasis. These patients can be managed by surgery, radiotherapy or their combination, depending on the presence of risk factors, the moment at which such risk factors are detected, patient-related clinical conditions, medical provider expertise and institutional facilities.Keywords
This publication has 57 references indexed in Scilit:
- Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biologyHead & Neck, 2011
- Indication for elective neck dissection for N0 carcinoma of the parotid gland: a single institution's 20-year experienceActa Oto-Laryngologica, 2010
- Interpretation of treatment outcome in the clinically node‐negative neck in primary parotid carcinoma: A systematic review of the literatureHead & Neck, 2009
- Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid GlandAnnals of Surgical Oncology, 2006
- Sentinel Lymph Node Biopsy in Parotid Gland CarcinomaClinical Nuclear Medicine, 2006
- Clinical Prognostic Factors in Malignant Parotid Gland TumorsOtolaryngology–Head and Neck Surgery, 2005
- Expression of Cell Cycle–Regulated Proteins pRB2/p130, p107, E2F4, p27, and pCNA in Salivary Gland Tumors: Prognostic and Diagnostic ImplicationsClinical Cancer Research, 2005
- Elective neck dissection versus observation in primary parotid carcinomaOtolaryngology–Head and Neck Surgery, 2005
- Carcinoma ex pleomorphic adenoma: A clinicopathologic reviewHead & Neck, 2001
- Management of Clinically Negative Cervical Lymph Nodes in Patients with Malignant Neoplasms of the Parotid GlandORL, 2001